“健康世界峰会第13次肠道菌群”揭示了如何将尖端研究应用于临床实践。

峰会展示了有关冠状病毒，植物和乳制品蛋白质以及益生菌的最新微生物组研究。

A gathering of medical professionals over the weekend in Washington, D.C., at the ‘13th Gut Microbiota for Health World Summit’ highlighted how cutting-edge research on gut microbiome science is being applied to clinical practice.

周末在华盛顿特区举行的医疗专业人员聚集在“第13次肠道微生物群”的卫生世界峰会上，强调了如何将有关肠道微生物组科学的尖端研究应用于临床实践。

Organised by the American Gastroenterological Association (AGA) and the European Society of Neurogastroenterology and Motility (ESNM), the event brought together clinicians, researchers, nutritionists, and dietitians from across the globe.

由美国胃肠病学协会（AGA）和欧洲神经胃肠病学与运动学会（ESNM）组织，该活动将来自全球的临床医生，研究人员，营养学家和营养师汇集在一起​​。

The summit showcased the latest microbiome research on coronavirus, plant and dairy-based protein, as well as probiotics.

峰会展示了有关冠状病毒，植物和乳制品蛋白质以及益生菌的最新微生物组研究。

A novel study found that the gut microbiome in children is altered post-COVID-19 infection, much like it is in adults.

一项新颖的研究发现，儿童的肠道微生物组发生了改变后19岁后感染，就像成年人一样。

Researchers from the University of Florence and colleagues in Italy carried out the study, which is published in the journal Gut, and saw a significant decrease in beneficial bacteria, like Lacticaseibacillus and Bifidobacterium, in children who had COVID-19 compared to those who didn’t.

意大利佛罗伦萨大学和同事的研究人员进行了这项研究，该研究发表在《肠道杂志》上，与与那些没有的人相比，有益细菌的有益细菌（如乳酸酶杆菌和双歧杆菌）有显着减少，例如乳酸酶杆菌和双歧杆菌。

These bacteria help reduce inflammation and support gut health. Children with lingering symptoms also showed different types of bacteria, in addition to elevated markers of inflammation and decreased barrier function in the gut.

这些细菌有助于减少炎症并支持肠道健康。患有挥之不起的儿童还显示出不同类型的细菌，除了炎症的标记升高和肠道障碍功能降低。

Future research will examine immune responses and potential microbiome-targeted therapies for persistent post-COVID-19 symptoms.

未来的研究将检查免疫反应和潜在的微生物组靶向疗法，用于持续的旋转后症状。

In another study, researchers analysed 35 plant-based and 23 dairy-based foods and found that nearly 50% of tested plants and milk and dairy products contain S100B, a helpful protein that binds calcium.

在另一项研究中，研究人员分析了35种基于植物的基于乳制品和23种乳制品食品，发现近50％的测试植物，牛奶和乳制品中含有S100B，S100B是一种结合钙的有用蛋白质。

The study, carried out by researchers at the University of Naples Federico II and colleagues in Italy, and published in the journal Molecular Nutrition & Food Research, suggested that S100B may interact with gut bacteria to promote a healthy microbiome, potentially influencing inflammatory bowel disease (IBD).

这项研究由那不勒斯大学费德里科II和意大利同事的研究人员进行，并发表在《分子营养与食品研究》杂志上，这表明S100B可能会与肠道细菌相互作用，以促进健康的微生物组，潜在影响炎症性肠病（IBD）。

The findings open the door for future dietary applications, such as using S100B in supplements and nutraceuticals.

这些发现为将来的饮食应用打开了大门，例如在补充剂和营养中使用S100B。

Meanwhile, a meta-analysis of 10 studies, including 2,345 patients, showed that probiotics significantly reduced abdominal pain, bloating, and vomiting after a colonoscopy.

同时，一项对包括2345例患者在内的10项研究的荟萃分析表明，结肠镜检查后益生菌可显着减轻腹痛，腹胀和呕吐。

While there was no significant reduction in nausea, constipation, gas, or diarrhoea, these findings suggest probiotics could improve patient recovery and encourage more individuals to undergo the crucial procedure.

尽管恶心，便秘，气体或腹泻没有显着减少，但这些发现表明益生菌可以改善患者的康复，并鼓励更多的人接受关键手术。

The researchers, from the University of Florence and colleagues in Italy, conducted a systematic review and meta-analysis of relevant studies published up to January 2023, which was cross-posted on the preprint server MedRxiv ahead of peer review.

意大利佛罗伦萨大学和同事的研究人员对2023年1月发表的相关研究进行了系统的综述和荟萃分析，该研究在同行评审之前在Preprint Server MedRxiv上进行了交叉宣传。

Their analysis included 10 studies involving a total of 2,345 patients who underwent colonoscopy and were randomly assigned to receive either a probiotic supplement or a placebo.

他们的分析包括10项研究，涉及总共进行结肠镜检查并随机分配接受益生菌补充剂或安慰剂的患者。

The results showed that patients who received a probiotic supplement experienced a significantly lower incidence of abdominal pain, bloating, and vomiting compared to those who received a placebo.

结果表明，与接受安慰剂的患者相比，接受益生菌补充剂的患者的腹痛，腹胀和呕吐的发生率明显降低。

However, no significant difference was observed in the occurrence of nausea, constipation, gas, or diarrhoea between the two groups.

但是，两组之间的恶心，便秘，气体或腹泻的发生尚无明显差异。

These findings suggest that probiotics may help to mitigate some of the common side effects associated with colonoscopy, which could improve patient recovery and encourage more individuals to undergo the procedure.

这些发现表明，益生菌可能有助于减轻与结肠镜检查相关的一些常见副作用，这可以改善患者的康复，并鼓励更多的人接受该程序。